BioNeutral Announces Sales & Distribution Agreement With Alpha Tech Pet, Inc.
March 26 2014 - 7:45AM
Marketwired
BioNeutral Announces Sales & Distribution Agreement With Alpha
Tech Pet, Inc.
NEWARK, NJ--(Marketwired - Mar 26, 2014) - BioNeutral Group,
Inc. (OTCBB: BONU) (OTCQB: BONU) today announced that it has
entered into a Sales and Distribution Agreement with Alpha Tech
Pet, Inc. Alpha Tech Pet provides innovative solutions for
veterinary medical and animal care applications with a full line of
detergents, disinfectants and microbial control technologies.
This agreement is another key component of an impressive slate
of market leaders that we have strategically aligned ourselves with
during the past 4 months. Alpha Tech Pet's direct access to
the veterinary community and commercial animal care marketplace,
coupled with their leading position in these industries, is a true
winning combination for BioNeutral and its customers. YGIENE™ will
round out their sterilant/disinfectant offering by adding a
high-powered Ready-To-Use sterilant to their already strong product
portfolio. Furthermore, Shawn Seitz, DVM, the President
and CEO of Alpha Tech Pet, is recognized as an industry expert whom
many in the veterinary community, sheltering, animal hospitality
and grooming industries look to for recommendations for their
sterilization and disinfection protocols. Our YGIENE™ chemistry,
proven to kill all microbial life, has gained a significant ally
that is directly focused on microbial control in this growing
market segment.
"We are delighted to have partnered with BioNeutral in bringing
their YGIENE sterilant/disinfectant to the Animal Care
marketplace," commented Dr. Shawn Seitz. "YGIENE fills a
critical gap for targeting infection reductions and reducing
disease transmission in Animal Care facilities. By offering
veterinarians and animal care professionals a true surface
sterilant/disinfectant, a higher level of disease control is now
available for combating infections and reducing communicable
diseases. Animal Care Professionals now have an effective
means, not previously available, for moving beyond simple
disinfection protocols to actual sterilization of
surfaces. YGIENE is ideally suited for sterilizing surgical
tables, exam tables, grooming tables, tubs, cages, and non-invasive
equipment. This product enhances a facility's overall
sanitation capability and arms our industry with a much needed
additional tool for combating diseases."
"Alpha Tech Pet has a 24 year track record of satisfied
customers," said Ray Dunning, Sr. Vice President of Sales for
BioNeutral. "If you are a veterinary facility, animal shelter,
humane society, pet resort, kennel, aviary, zoo, institution or pet
shop you will commonly look to Alpha Tech Pet for their expertise
in facility hygiene. Alpha Tech Pet is uniquely positioned to bring
our highly effective technology to a whole new set of customers
that are committed to reducing infections in the veterinary and
animal care marketplace."
About Alpha Tech Pet, Inc. Alpha Tech Pet, Inc. was founded in
Littleton, Massachusetts in 1989 by veterinarian Dr. Shawn Eliot
Seitz. With over 29 years of diverse Animal Care Industry
experience, Dr. Seitz has utilized his knowledge and experience to
develop Alpha Tech Pet's existing line of environmentally sensitive
products. Their current product offerings include disinfectants,
sanitizers, kennel odor control and cleaning products, drain
maintenance, pet laundry items, pumps and containers, and chemical
dispensers, all specifically made for the animal care
industry. Alpha Tech Pet offers products and the expertise to
make facilities cleaner, safer, and more environmentally sensitive.
Alpha Tech Pet prides themselves in their innovation, excellence in
customer service and extensive industry expertise, and they stand
behind all their products to ensure complete customer satisfaction.
Find Alpha Tech Pet at www.alphatechpet.com.
About BioNeutral Group, Inc. Headquartered in Newark, New
Jersey, BioNeutral Group, Inc. is a specialty technology-based
life-science company that has developed a technology platform that
neutralizes harmful environmental contaminants, toxins and
dangerous micro-organisms including bacteria, viruses, mold, fungi
and spores. BioNeutral's products, YGIENE™ and OGIENE™, kill germs
and clean surfaces with a dramatic increase in speed and power over
their rivals in the marketplace. BioNeutral's proprietary platform
technology has been proven effective in surface, water and airborne
applications. Its antimicrobial line of products under the YGIENE™
brand has been approved by the EPA for sale in the United States.
For more information on BioNeutral, including a listing of company
products, leadership and background please visit
www.bioneutral.com.
Find us on Facebook:
http://www.facebook.com/pages/BioNeutral-Group/149109938452393
Follow us on Twitter:
http://twitter.com/bioneutralgroup
Forward-Looking Statements: This release contains
certain "forward-looking statements" relating to the business of
the Company and its subsidiary companies. These forward-looking
statements are often identified by the use of forward-looking
terminology such as "believes," "expects" or similar expressions.
Such forward-looking statements involve known and unknown risks and
uncertainties that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. Investors should not place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. The Company's actual results could differ
materially from those anticipated in these forward-looking
statements as a result of a variety of factors, including those
described in the Company's filings with the Securities and Exchange
Commission. BioNeutral routinely tests its formulations against
those of its competitors. The results are published to let
shareholders know how the Company's technology compares with known
formulations in the market place. Any product claim for
antimicrobial activity requires approval from the EPA or FDA,
depending upon where and how the formulations are used. The EPA has
approved and registered the Company's data and findings specific to
Ygiene-206. BioNeutral's antimicrobial formulations will be
marketed under the brand name Ygiene® and are available for sale in
the United States.
CONTACT FOR THE COMPANY: Mark Lowenthal CEO BioNeutral Group,
Inc. +1-973-577-8003